← Open Payments lookup

LORI NAJAR: Open Payments

NPI 1669529129 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,652 in 174 payments from 22 companies in 2025. Trend: 2023 $1,928 · 2024 $3,176 · 2025 $4,652

Food & beverage: $3,602Consulting: $1,050
CompanyPaymentsAmount
Janssen Biotech, Inc.28$1,586
ABBVIE INC.42$752
Celltrion USA Inc.13$275
Madrigal Pharmaceuticals11$260
QOL Medical, LLC9$239
Phathom Pharmaceuticals, Inc.10$226
Aimmune Therapeutics, Inc.12$175
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$173
Janssen Scientific Affairs, LLC1$145
GENZYME CORPORATION4$117

Products named: TREMFYA, VEGZELMA, REZDIFFRA, Sucraid, DUPIXENT, VOQUEZNA, CREON, ZENPEP.

Industry payments across TX — which companies pay providers there.